Results for tag: "Pneumococcal Disease Drug"

The Pneumococcal Disease Drug market is a subset of the larger Respiratory Drugs market. It is composed of drugs used to treat and prevent pneumococcal infections, which are caused by the bacteria Streptococcus pneumoniae. These infections can range from mild to severe, and can include pneumonia, meningitis, and bacteremia. Pneumococcal Disease Drugs are typically administered as a vaccine, or as an antibiotic. Vaccines are used to prevent infection, while antibiotics are used to treat existing infections. The Pneumococcal Disease Drug market is highly competitive, with many companies offering products. Some of these companies include Pfizer, GlaxoSmithKline, Merck, Sanofi, and AstraZeneca. Show Less Read more